FTK Investor Alert: Johnson Fistel Encourages Flotek Industries, Inc. Investors to Contact the Firm Ahead of October 26, 2026 Lead Plaintiff Deadline

A securities class action alleges Flotek made misleading statements about a PREPA power project expected to represent approximately $400 million in potential revenue backlog, or roughly 57% of backlog; the allegations have not been proven and no class has been certified. After a Wolfpack Research report alleged the opportunity had been canceled, Flotek shares fell 20.01% on Aug. 17, then declined a further 5.72% on Aug. 18 and 6.85% on Aug. 19 as Flotek disclosed PREPA’s instructions to halt work and later confirmed termination. Investors have until Oct. 26, 2026, to seek appointment as lead plaintiff.

Analysis

The incremental signal is not the filing itself; it is whether the PREPA episode reveals a broader weakness in Flotek’s backlog underwriting and counterparty diligence. A project described as a large potential backlog item is not equivalent to contracted, financeable revenue. If that opportunity was a substantial share of reported backlog, investors should discount headline backlog until Flotek demonstrates executable contracts, credible counterparties, and conversion to revenue and cash. The complaint is an allegation, not a finding, and a law-firm announcement is not independent evidence of liability. Near term (days), litigation headlines may add volatility but are unlikely to change cash flows. Over 1–3 months, the key catalysts are company disclosure on backlog composition, replacement awards, and any guidance reset; legal discovery is a slower, uncertain catalyst. Over 6–18 months, the structural question is whether customers and partners require stronger proof of project readiness before assigning Flotek work. Contrarian view: after the August repricing, treating this filing as a fresh fundamental shock risks selling stale news. A credible update showing the remaining backlog is diversified and converting could support a sharp recovery; conversely, further cancellations or weak cash conversion would indicate the market has not fully recognized execution risk. The thesis is falsified by verified replacement business and stable guidance, or strengthened by additional project suspensions and downward revisions.

Key Decisions for Investors

• Do not initiate a short solely on the October litigation announcement; the underlying project termination and price reaction were already public in August, while the complaint remains unproven.
• Keep FTK underweight / avoid chasing rebounds until management provides a reconciled backlog bridge: signed versus conditional awards, counterparty funding and approvals, expected timing, and revenue conversion. Reassess if those disclosures show diversified, executable backlog and stable guidance.
• For existing exposure, size risk around the possibility of further estimate cuts rather than assumed legal damages. Track quarterly backlog conversion, cancellations, operating cash flow, and guidance; deterioration across these metrics would support reducing exposure.
• Treat any options expression as a watch item, not a recommendation, until FTK options liquidity, implied volatility, and the next disclosure calendar are checked. A sharp volatility premium could make event protection unattractive despite the execution uncertainty.